What is Xealth?
Founded in 2017 and headquartered in Seattle, Washington, Xealth operates at the intersection of clinical practice and digital transformation. The company provides a sophisticated digital health platform that enables health systems to prescribe, integrate, and monitor digital health tools directly within existing electronic health record (EHR) environments. By streamlining these processes, Xealth effectively reduces the administrative burden on clinicians while simultaneously enhancing the patient experience through personalized digital care pathways.
With a user base exceeding 100,000 physicians, the platform has become an essential component of the digital health ecosystem. Its ability to offer consolidated reporting and streamlined communication makes it a preferred solution for large-scale health organizations looking to optimize their digital health portfolios and improve overall clinical outcomes.
How much funding has Xealth raised?
Xealth has raised a total of $15.5M across 3 funding rounds:
Angel/Seed
$8.5M
Debt
$1M
Unspecified
$6M
Angel/Seed (2017): $8.5M with participation from Draper Fisher Jurvetson, Froedtert Health, Providence, UPMC, and Hennepin Healthcare System
Debt (2020): $1M led by PPP
Unspecified (2020): $6M supported by Cerner Corporation and LRVHealth
Key Investors in Xealth
Draper Fisher Jurvetson
Draper Fisher Jurvetson is a leading venture capital firm with a global presence, dedicated to identifying and providing capital for extraordinary entrepreneurs determined to change the world.
Cerner Corporation
Cerner Corporation is a major American supplier of health information technology services, devices, and hardware, focusing on the digitization of clinical data.
LRVHealth
LRVHealth is a venture capital firm focused on finding, investing in, and building disruptive new digital health, devices, and diagnostic companies.
What's next for Xealth?
With this latest capital infusion, Xealth is well-positioned to accelerate its product development and expand its footprint across the healthcare landscape. The strategic focus will likely center on deepening EHR interoperability and enhancing the platform's analytical capabilities to support more complex, data-driven care models. As the industry shifts toward value-based care, Xealth's ability to demonstrate measurable improvements in clinician efficiency and patient engagement will be paramount to its long-term success.
Furthermore, the continued support from strategic health system investors suggests that Xealth will remain at the forefront of digital health orchestration. Future initiatives are expected to focus on scaling the platform to accommodate a broader range of digital therapeutics and remote monitoring solutions, ensuring that health systems can effectively manage the growing complexity of the digital health market.
